Search results
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks· 3 days agoInvestors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical (COLL Quick QuoteCOLL - Free Report) reports first-quarter 2024 results on May 9, 2024. Collegium ...
Scott Perry’s Democratic opponent Janelle Stelson thinks she can get support from Republicans. She...
Philly.com· 17 hours agoFormer news anchor Janelle Stelson, the Democratic nominee for central Pennsylvania’s 10th...
Aging Matters: Shepherd's Center book sale Thursday-Saturday
Winston-Salem Journal· 4 days agoThe Shepherd’s Center of Greater Winston-Salem will hold its 37th annual used book sale from 9 a.m....
If You Invested $1000 in Elevance Health a Decade Ago, This is How Much It'd Be Worth Now
Zacks· 21 hours agoThis factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. FOMO, or the fear of missing out, also plays a role in investing ...
New survey finds 75% of Americans feel mental health takes back seat to physical health within US...
Medical Xpress· 17 hours agoThree-quarters of Americans feel that mental health conditions are identified and treated with much...
Health care, infrastructure and farm bill are Cabrera priorities
Billings Gazette· 6 days agoEditor’s note: This is one of 12 profiles featuring a candidate in Montana’s Second Congressional...
JD Supra: Healthcare Authority Newsletter
JD Supra· 6 days agoAn executive order signed by President Joe Biden in October directed the HHS to create a comprehensive plan for assessing AI before it goes to market, and monitoring performance ...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com· 2 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 3 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
FDA finalizes lab test regulations with more flexibility
Politico· 1 day ago“It’s a shame that an administration committed to ending cancer as we know it has retreated from this critical public health strategy,” Senate Majority Whip Dick Durbin (D ...